Pharmacokinetics of 8-methoxypsoralen in the dog
β Scribed by J. G. Monbaliu; F. M. Belpaire; R. A. Braeckman; M. G. Bogaert
- Publisher
- John Wiley and Sons
- Year
- 1988
- Tongue
- English
- Weight
- 384 KB
- Volume
- 9
- Category
- Article
- ISSN
- 0142-2782
No coin nor oath required. For personal study only.
β¦ Synopsis
The pharmacokinetics of 8-MOP were studied in six dogs following intravenous administration of 2 mg kg-'. In most animals a bi-exponential decline of the plasma level profile was observed. The calculated pharmacokinetic parameters varied considerably between the different dogs. The mean half-lives of distribution and of elimination were 0.20 h and 2.17 h, respectively. The average total plasma clearance was 0.51 1 kg-I h-.
Following both oral and intravenous administration of doses of 1, 3, and 10 mg kg-I, non-linear kinetics were found. Non-linearity was confirmed following administration of the substance at increasing infusion rates.
Finally in four dogs, extraction by the liver was calculated by measuring 8-MOP concentration in the femoral artery and in a hepatic vein after intravenous administration of 1 mg kg-I. The extraction varied from animal to animal (18 per cent to nearly 100 per cent). Administration of an additional dose of 3 mg kg-' in two of the dogs led to a decreased extraction.
π SIMILAR VOLUMES
Reboxetine, (RS)-2-[(RS)-alpha-(2-ethoxyphenoxy)benzyl]morpholine methanesulphonate, is a racemic compound and consists of a mixture of the (R,R)- and (S,S)-enantiomers. The pharmacokinetics of reboxetine enantiomers were determined in a crossover study in three male beagle dogs. Each animal receive
The pharmacokinetics of total and free tiazofurin, an antineoplastic agent, was studied in healthy mongrel dogs following intravenous and oral administration of the drug. The free fraction of tiazofurin was obtained from plasma by an ultrafiltration technique using a micropartition system. Total and
## Abstract The pharmacokinetics of HIβ6 were studied following intravenous administration to beagle dogs (__n__ = 7). The bioavailability of two different strength intramuscularly administered doses was also determined in the same animals. After a 20 mg kg^β1^ intravenous dose, the mean (Β±S.D.) in
## Abstract The pharmacokinetics of cannabidiol (CBD) and six of its urinary metabolites was investigated in dogs. CBD was administered intravenously to three dogs, and urine was collected at specified time intervals over a period of 30h. The apparent terminal halfβlife of CBD calculated from the s
The pharmacokinetics of the cardioselective ,!hadrenoreceptor blocking agent atenolol have been determined following intravenous and oral dosing t o the dog. After intravenous administration at 200mg the blood levels of parent drug were found to decay tri-exponentially with a final elimination phase